NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- (“Syndax”) (NASDAQ: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, has entered into privately negotiated subscr ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Learn about AARP Membership Help Register Login Login Hi ...

Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM), a leading supplier in the motor vehicle aftermarket industry, announced today that it ...

The vast majority (96 percent) of lesbian, gay, bisexual, transgender and queer (LGBTQ+) adults are worried about the ...

The release-notes platform now publishes every update through three surfaces: a public page, an in-app widget, and a stable Markdown URL ...